Intended for healthcare professionals

Letters Depression in pregnancy

Paucity of data on the safety of drugs for treating depression in pregnancy

BMJ 2016; 353 doi: (Published 11 May 2016) Cite this as: BMJ 2016;353:i2582
  1. Alain Braillon, senior consultant1,
  2. Susan Bewley, professor of complex obstetrics2
  1. 1University Hospital. 80000 Amiens, France
  2. 2Women’s Health Academic Centre, St Thomas’ Hospital, London SEI 7EH, UK
  1. braillon.alain{at}

The otherwise excellent review of depression in pregnancy deserves comment regarding the “What you need to know” box.1

Who will “Offer all women education about mental health problems in pregnancy, treatment options, and the effect on themselves and their offspring”? Drug safety is a major problem because children and pregnant women are vulnerable populations. Data to ascertain the benefit:harm ratio or guide dosing are …

View Full Text

Log in

Log in through your institution


* For online subscription